Cargando…
Targeting lncRNAs in programmed cell death as a therapeutic strategy for non-small cell lung cancer
Lung cancer is a leading cause of cancer-related mortality worldwide, with non-small cell lung cancer (NSCLC) being the most common histological type. Owing to the limited therapeutic efficacy and side effects of currently available therapies for NSCLC, it is necessary to identify novel therapeutic...
Autores principales: | Luo, Yanqin, Li, Jingyang, Yu, Peng, Sun, Jiayi, Hu, Yingfan, Meng, Xianli, Xiang, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980082/ https://www.ncbi.nlm.nih.gov/pubmed/35379783 http://dx.doi.org/10.1038/s41420-022-00982-x |
Ejemplares similares
-
LncRNAs and regulated cell death in tumor cells
por: Wu, Yingying, et al.
Publicado: (2023) -
LncRNAs in Non-Small-Cell Lung Cancer
por: Ginn, Lucy, et al.
Publicado: (2020) -
LncRNAs in Stem Cells
por: Hu, Shanshan, et al.
Publicado: (2016) -
The Function and Therapeutic Potential of lncRNAs in Cardiac Fibrosis
por: Nie, Xiang, et al.
Publicado: (2023) -
Associating lncRNAs with small molecules via bilevel optimization reveals cancer-related lncRNAs
por: Wang, Yongcui, et al.
Publicado: (2019)